Patents/Assignees

Takeda Pharmaceuticals U.S.A., Inc.

2 patents in portfolio

US12485136utility2025
Methods for the Treatment of Trinucleotide Repeat Expansion Disorders Associated with MLH3 Activity
0 cites
US12297432utility2025
Oligonucleotides for the Treatment of Nucleotide Repeat Expansion Disorders Associated with MSH3 Activity
0 cites